Newsroom

Redwood City, Calif. – March 23, 2026 – Prenuvo, the leader in whole body MRI for proactive health screening, today announced the launch of its membership program. Designed to complement the annual physical, the membership provides a structured, year-over-year view of health—bringing together whole-body MRI, comprehensive biomarker tracking, and integrated clinical guidance within a single, standardized preventive platform.

As proactive healthcare grows in popularity, a clear differentiator is emerging: not all screening services – and not all interpretations – are created equal. With over 170,000 scans completed, Prenuvo’s memberships address this critical but often overlooked issue: variability in how proactive screening is performed, read, and tracked year over year.

‍

The Hidden Variable in Whole Body Screening: Not All MRIs Are Created Equal

Some whole body MRI companies operate through outsourced imaging partners, which can involve varying equipment, software, and radiologists who read screening exams intermittently alongside other diagnostic work. These differences may affect the consistency of year-over-year comparisons. 

“Effective health monitoring benefits from a reliable baseline,” said Andrew Lacy, Prenuvo founder and CEO. “At Prenuvo, we control the full experience, from hardware and software to radiology interpretation, within a single standardized system. When members return, they’re gaining consistent, comparable insights into how their health is changing and where action may be needed.”

Prenuvo manages every part of the scanning process. Its detailed Whole Body Scan uses the same 60-minute protocol to generate over 1.3 billion data points to detect hundreds of potential conditions across major systems – including the brain, spine, and organs – all without radiation or contrast agents. Dedicated board-certified radiologists consistently focused on whole body screening interpret image findings, complemented by detailed lab panel assessments reviewed by Prenuvo providers, building a detailed picture of health that can be measured and improved over time. 

"Screening whole body MRI is a new interdisciplinary pathway requiring a specific kind of mastery that greatly benefits from vertical integration," says Dr. Dan Durand, CMO and President at Prenuvo. "Experience matters at every step in the patient journey delivered by the 100+ providers in Prenuvo Medical Group. Our board-certified radiologists live in this model daily, structuring their interpretations according to the best practices shaped by 170,000 patients and counting. To ensure this data is actionable, our radiologists, preventative care physicians, and nurse practitioners collaborate as a team to contextualize these findings, empowering patients to take charge of their health.”

Introducing Prenuvo Memberships

Prenuvo’s new membership program offers three tiers designed to not only provide patients with financial savings but also support continuous, data-driven proactive insights:

• Core Membership – $1,199 annually: Our entry-level proactive health membership that includes a Focused Scan and a lab panel assessment to learn your health baseline.

• Comprehensive Membership – $2,499 annually: A proactive health assessment that pairs our Whole Body Scan with detailed lab panels to provide information about multiple areas of the body. 

• Executive Membership – $3,999 annually ($4,499 at New York clinic): Our most in-depth membership combines a Whole Body Scan, Brain Health Assessment, Body Composition Analysis, and our most detailed lab panel assessment.  

Memberships are available in 21 clinic locations across North America. No matter where members live, travel, or relocate, they can expect the same protocols, the same technology standards, and the same specialized expertise from Prenuvo Medical Group guiding their care.

To learn more about Prenuvo’s membership model and schedule a scan, visit www.prenuvo.com. To hear patient stories, visit https://prenuvo.com/stories.

About Prenuvo:

Prenuvo makes proactive health screening seamless and more widely accessible. Combining high-quality technology with radiation-free and non-invasive imaging assessments, Prenuvo’s patient-centric design is optimized to assess the body holistically, providing individuals with a detailed overview of their health.  Prenuvo’s exclusively-affiliated Radiology group partners consist of 100+ radiologists who help risk-stratify each patient report, keeping in mind healthcare complexities from the patient’s perspective, the treating clinician’s perspective, and the healthcare system’s perspective.

Prenuvo currently operates in 26 clinics across North America, Australia, and Europe. To find your nearest Prenuvo, please visit here. Learn more at www.prenuvo.com and connect with Prenuvo here. 

Media Contact:

Christine Alabastro

media@prenuvo.com 

###

‍

New York, NY — [January 8th, 2026] — Baker Health, a concierge primary care platform focused on personalized and integrative wellness, announced a new partnership with Prenuvo, the leader in whole body MRI for proactive health screening. This collaboration gives Baker Health Members streamlined access to Prenuvo’s radiation-free, non-invasive whole-body MRI technology, providing comprehensive health insights designed to support proactive, personalized care.

Prenuvo offers advanced screening services that include whole body MRI, an FDA-cleared AI-powered body composition analysis, brain health assessments, and functional and conventional blood biomarkers. In under 60 minutes, Prenuvo captures millions of data points, offering individuals a holistic view of their health through scans engineered for speed, accuracy, comfort, and safety.

“At Baker Health, we are committed to giving our Members the most advanced tools to understand and optimize their health,” said Dr. Iyad Baker, Co-Founder of Baker Health. “Partnering with Prenuvo enhances our ability to deliver personalized, proactive care and help support long-term wellness.”

“This partnership brings advanced imaging into an ongoing primary care relationship,” said Andrew Lacy, founder and CEO of Prenuvo. “Prenuvo’s whole body MRI gives Baker Health clinicians objective, whole body health insights that complement labs and clinical history, helping guide preventive conversations and long-term health planning.”

Prenuvo’s technology and clinical partnerships support individuals and their healthcare teams with comprehensive insights that help contextualize health concerns clearly. With more than 150,000 scans completed and an exclusively-affiliated radiology group of over 100 board-certified radiologists, Prenuvo provides detailed whole body imaging designed to help identify various health abnormalities, including metabolic disorders, spinal degeneration, brain aneurysms, auto-immune disorders, solid tumors as early as stage 1, and non-cancerous conditions such as cysts, hematomas, and abscesses. Today, 1 in 20 Prenuvo scans results in a potentially life-saving diagnosis.*

This partnership reinforces Baker Health’s commitment to prevention-forward, relationship-driven medicine. By integrating Prenuvo’s advanced imaging into Baker Health’s tech-enabled, seamlessly connected ecosystem, Members gain access to a more comprehensive, proactive approach to optimizing their long-term health and well-being.

*Disclaimer: Based on our internal data analysis, 5% of Prenuvo scans have helped detect a potentially life-saving condition. This reflects in particular the combined prevalence of radiologically-suspected pre-cancerous/cancerous-findings or CSD4+ as defined in our whole body MRI screening practice.

About Baker Health

Baker Health delivers concierge primary care focused on prevention, wellness, and lifestyle optimization. Combining personalized care with integrative services — including nutrition, mental health, weight management, and lifestyle medicine — Baker Health provides Members with a holistic, whole person approach to long-term health and longevity. Through extended visits, seamless access to doctors, and a curated specialty network, Baker Health ensures Members receive proactive guidance and actionable insights to optimize their well-being.

Baker Health serves Members across multiple locations and provides a tech-enabled experience through the proprietary Baker Health app, offering 365-day access to doctors and care teams. 

www.bakerhealth.com

About Prenuvo

Prenuvo makes proactive health screening seamless and more widely accessible. Combining advanced technology with radiation-free and non-invasive whole body scans, Prenuvo’s patient-centric design is optimized to assess the body holistically, providing individuals with a comprehensive overview of their health in under 60 minutes. Prenuvo’s exclusively-affiliated Radiology group partners consist of 100+ radiologists who help risk-stratify each patient report, keeping in mind healthcare complexities from the patient’s perspective, the treating clinician’s perspective, and the healthcare system’s perspective.

Prenuvo clinics are currently open in New York, Buffalo, Redwood City, Los Angeles, Pasadena, Irvine, Dallas, Houston, Boca Raton, Chicago, Las Vegas, Bethesda (DC metro area), Atlanta, Vancouver, and Minneapolis. Learn more at www.prenuvo.com. 

###

‍Global expansion marks a major step for preventative health leader as demand grows for proactive screening technology 

London, United Kingdom - 24 November – Prenuvo, the company leading proactive whole body MRI imaging for the early detection of cancer and other diseases, today announced the opening of its first UK clinic in London's Fitzrovia district. The expansion marks a significant milestone for the company as it brings comprehensive preventative screening beyond North America and Australia for the first time, having now completed more than 150,000 scans across 27 clinics globally.

Located at 32-36 Great Portland Street situated between London's medical district and shopping district, the two-storey clinic offers the UK and European residents access to advanced whole-body MRI technology that can help identify potential health concerns often before symptoms appear.

The London clinic opening comes at a critical moment as the UK faces significant healthcare challenges, with NHS England data revealing historic pressures with more than 7.6 million people waiting for diagnostic tests. Prenuvo’s entry into the UK offers  individuals a proactive option to gain comprehensive and timely health insights to support their health

“When we founded Prenuvo, we believed early detection could fundamentally change the trajectory of healthcare,” said Andrew Lacy, Founder and CEO of Prenuvo. “Opening in London brings that vision to one of the world’s most important medical hubs. People across the UK are looking for personalised insight and a health assessment that goes far deeper than a standard physical, and Prenuvo is proud to offer an approach that delivers both—today.”

Rather than waiting for symptoms to emerge, Prenuvo's technology is designed to identify potential health concerns – including most solid tumour as early as stage 1, brain aneurysms, metabolic disorders, and hundreds of other conditions – all without radiation and contrast, in under an hour. Based on internal data analysis, approximately 1 in 20 Prenuvo scans alerts patients to potentially life-saving diagnoses*

“Opening Prenuvo in the UK is a tremendous privilege and responsibility,” says Dr. Tahreema Matin, DPhil, MBBS, AICSM, BSc(HONS), FRCR, UK Medical Director, Prenuvo. “The clinical opportunity here is significant. Detecting a tumour at an earlier stage generally allows for different treatment options and potentially better outcomes. What we're offering is comprehensive, high-resolution MRI across the entire body in 45 minutes, interpreted by consultant radiologists who specialise in whole-body imaging. We are honoured to serve UK patients with detailed, timely insights to help them take a more proactive approach to health.”

The Prenuvo Whole Body Scan

Prenuvo's advanced approach to screening is based on 15+ years of clinical practice and the company holds the  world's largest dataset of whole-body MRI. The comprehensive screening offers:

• 45-minute scan – Fast, non-invasive imaging in a comfortable open-bore MRI machine
• No radiation or contrast – Safe screening without the risks associated with ionising radiation or contrast agents
• Whole-body scan at £2,499 – Prenuvo’s  most comprehensive scan that assesses the anatomy, including major organs and spine
• 500+ conditions – Including most solid tumours (which can be detected as early as stage 1), brain aneurysms, metabolic disorders, spinal degeneration, autoimmune conditions, cysts, and more
• Specialised radiologist interpretation – Every scan is thoroughly reviewed by radiologists with specialised expertise in whole-body MRI

The London clinic launch represents the first phase of Prenuvo's European growth strategy, with the company evaluating additional European cities for future expansion.

For more information on Prenuvo's London clinic and to book a scan appointment, visit prenuvo.com.

About Prenuvo

Prenuvo makes proactive health screening seamless and more widely accessible. Combining advanced  technology with radiation-free and non-invasive whole body scans, Prenuvo’s patient-centric design is optimised to assess the body holistically, providing individuals with a comprehensive overview of their health in under 60 minutes. Prenuvo’s exclusively-affiliated Radiology group partners consist of 100+ radiologists that help risk-stratify each patient report, keeping in mind healthcare complexities from the patient’s perspective, the treating clinician’s perspective, and the healthcare system’s perspective.

Prenuvo clinics are currently open in New York, Buffalo, Redwood City, Los Angeles, Pasadena, Irvine, San Diego, Scottsdale, Dallas, Houston, Denver, Chicago, Las Vegas, Boca Raton, St. Petersburg, Miami, Philadelphia, Bethesda (DC metro area), Atlanta, Vancouver, Seattle, and at the Hercules Research Center in Boston, and Minneapolis and an international clinic in Melbourne, Australia.Learn more at www.prenuvo.com.

Prenuvo is backed by leading venture capital firms and investors in health, fitness and category-defining consumer brands such as Felicis [investors in Fitbit (IPO), Guardant Health (IPO) and Ring (acq. by Amazon)], 23AndMe CEO Anne Wojcicki, Xavier Niel, Nest founder Tony Fadell, Eric Schmidt, Cindy Crawford, and Lasker award recipient Dr. Timothy A. Springer. 

‍

‍

*Based on internal data analysis, 5% of Prenuvo scans have helped detect a potentially life-saving condition. This reflects, in particular, the combined prevalence of radiologically-suspected pre-cancerous/cancerous findings or brain-aneurysms in our WB-MRI screening practices.

‍

AI-powered MRI study finds link between smoking and early signs of brain aging in 10,000+ healthy adults

Redwood City, CA — [July 23] — Prenuvo, the leading whole body MRI for proactive health screening, today announced its research has been published in Nature Partner Journal – Dementia (npj-Dementia). The research reveals a strong association between cigarette smoking and brain atrophy in a cohort of 10,134 healthy adults scanned using Prenuvo’s full-body MRI platform. Led by Dr. Somayeh Meysami, MD, Assistant Professor of Neurosciences at Saint John’s Cancer Institute and Clinical Research Scientist at the Pacific Brain Health Center, Pacific Neuroscience Institute (PNI), the study utilized advanced structural MRI and deep learning segmentation to show how smoking is linked to regions of the brain commonly affected in Alzheimer’s disease.

The full list of collaborators include: Somayeh Meysami, Saurabh Garg, Sam Hashemi, Nasrin Akbari, Ahmed Gouda, Yosef Gavriel Chodakiewitz, Thanh Duc Nguyen, Rajpaul Attariwala, Kellyann Niotis, David A. Merrill, and Cyrus A. Raji.

The research found that individuals with any history of smoking (measured by pack-years) had notably lower gray and white matter volumes compared to non-smokers. Greater cumulative exposure (more pack-years) significantly predicted volume reductions in key brain regions, including the temporal lobe, parietal lobe, hippocampus, precuneus, and posterior cingulate. The analysis also highlighted body mass index (BMI) as a contributing factor, suggesting that higher BMI may amplify the negative impact of smoking on brain structure.

“Our results clearly show that smoking significantly impacts brain health by its link to increased brain atrophy in areas critical to cognitive function,” said Dr. Somayeh Meysami, MD, lead author of the study. “These findings reinforce the urgent need for preventive measures addressing both smoking cessation and healthy weight management.”

Senior author Cyrus A. Raji, MD, PhD, Associate Professor of Radiology at Washington University in St. Louis added, “This work underscores the interconnected nature of lifestyle factors like smoking and obesity in accelerating brain aging. Understanding these relationships provides an essential foundation for developing targeted strategies aimed at preventing dementia and preserving cognitive health.”

The study’s design, utilizing a large sample size and sophisticated neuroimaging, makes a significant contribution to public health by identifying modifiable risk factors for cognitive decline and dementia. Future research will further explore how interventions targeting smoking and BMI might mitigate or even reverse these adverse effects.

“This is exactly the kind of insight that wasn’t measurable before. By combining high-fidelity imaging with the largest dataset of healthy brain scans and intelligent, accurate, and reproducible measurement of small brain structure using AI, we’re now able to quantify subtle but critical effects – like smoking-induced brain atrophy – with unprecedented clarity,” said Sam Hashemi, Vice President of Artificial Intelligence & Research at Prenuvo. “It’s a window into what becomes possible when AI meets population-scale precision imaging, opening the door to earlier detection, targeted prevention, and a deeper understanding of cognitive aging.” 

For more information on the study, read the whole study here.

About Prenuvo

Prenuvo makes MRI scanning for early detection of many types of cancer and many other diseases seamless and more widely accessible. Combining cutting-edge analysis technology with radiation-free and non-invasive whole body scans, Prenuvo’s patient-centric design is optimized to assess the body holistically and in under 60 minutes, compared with the several hours it would take to achieve this level of insight from conventional MRI scans. Prenuvo’s team of 100+ radiologists specializes in whole body MRI screenings to risk-stratify each patient report, keeping in mind healthcare complexities from the patient’s perspective, the treating clinician’s perspective, and the healthcare system’s perspective.

Media Contact: 

Christine Alabastro

prenuvo@vsc.co

Groundbreaking research using Prenuvo whole body MRI data earns the Alzheimer Award, awarded to Dr. Cyrus Raji by the Journal of Alzheimer’s Disease

SAN FRANCISCO — July 8, 2025 — Prenuvo, the leading whole body MRI for proactive health screening, today announced research powered by its imaging dataset has received the prestigious 2025 Alzheimer Award from the Journal of Alzheimer’s Disease (JAD). The award, granted for the last 25 years, honors one of the most impactful studies advancing the field of Alzheimer’s research in the past year and was selected by the international JAD Editorial board out of 800 submissions. 

The awarded study, “Exercise-Related Physical Activity Relates to Brain Volumes in 10,125 Individuals,” found that just 25 minutes of moderate to vigorous physical activity per week is linked to greater brain volume in regions vulnerable to Alzheimer’s, supporting exercise as a preventive strategy for dementia. The study used Prenuvo’s extensive normative dataset of proactive whole body MRI scans to identify structural brain changes in asymptomatic individuals that may precede clinical signs of Alzheimer’s. The study marks a significant step toward earlier, noninvasive detection of the neurodegenerative disease.

The full list of collaborators includes: Cyrus A. Raji, Somayeh Meysami, Sam Hashemi, Saurabh Garg, Nasrin Akbari, Thanh Duc Nguyen, Ahmed Gouda, Yosef Gavriel Chodakiewitz, and Rajpaul Attariwala.

“Our findings suggest that subtle brain structure changes linked to Alzheimer’s may be detectable earlier than previously believed, especially with access to high-resolution imaging and AI tools that can segment and analyze these small structures at scale,” said lead study author Dr. Cyrus Raji, PhD, Mallinckrodt Institute of Radiology, Washington University in St. Louis. “This research was facilitated by Prenuvo’s unique MRI dataset, which combines whole body imaging with high spatial resolution, enabling a precise level of structural detail.”

While traditional Alzheimer's diagnostics rely on PET scans and cerebrospinal fluid analysis, this study highlights how non-invasive, whole body MRI, paired with advanced analysis using AI, can reveal early indicators of cognitive decline in large, diverse populations. Prenuvo's anonymized imaging data allowed researchers to examine the structural brain correlates of Alzheimer’s in people without clinical symptoms, helping to push the field of early detection forward.

“Imaging-driven research can unlock earlier, more accessible ways to detect neurodegenerative disease,” said Sam Hashemi, Vice President of AI and Research at Prenuvo and study co-author. “This award underscores the potential of not just Prenuvo, but when proactive imaging using MRI and AI come together, they can reveal hidden signals in the brain that might otherwise go undetected. It points to a world where insights like these become part of routine care, not just research.”

The Journal of Alzheimer’s Disease gives the Alzheimer Award annually to a lead author whose paper has significantly advanced Alzheimer’s research. The award includes a bronze medal featuring Alois Alzheimer and a $7,500 honorarium to be presented at the Alzheimer’s Association International Conference in Toronto, Canada from July 27-31st, 2025.

The full paper is available here: https://journals.sagepub.com/doi/10.3233/JAD-230740 

About Prenuvo:

Prenuvo makes MRI scanning for early detection of many types of cancer and many other diseases seamless and more widely accessible. Combining cutting-edge analysis technology with radiation-free and non-invasive whole body scans, Prenuvo’s patient-centric design is optimized to assess the body holistically and in under 60 minutes, compared with the several hours it would take to achieve this level of insight from conventional MRI scans. Prenuvo’s team of 100+ radiologists specializes in whole body MRI screenings to risk-stratify each patient report, keeping in mind healthcare complexities from the patient’s perspective, the treating clinician’s perspective, and the healthcare system’s perspective.

Media Contact: 

Christine Alabastro

prenuvo@vsc.co

‍

At Prenuvo, we believe that answers to today’s most pressing health challenges are already inside us, if we know where to look. Using our proprietary dataset, which is the largest collection of whole-body MRI scans in primarily asymptomatic individuals in the world, our in-house AI research team and research partners are releasing two new studies that explore how everyday habits leave structural footprints in our bodies and brains.

Both studies have been presented at the 2025 ISMRM Annual Meeting (International Society of Magnetic Resonance).

Here’s what we found:

1. Just 2 drinks a day? Your brain and organs already know

While much of the research out there on alcohol focuses on those with alcohol use disorder, this study looked at people who drink moderately (two or more drinks a day) and found that even without clinical addiction, the effects are measurable and systemic.

In a study of over 1,100 people with no diagnosis of alcohol use disorder, moderate drinkers showed:

• Loss of brain volume in regions tied to memory, motor control, and decision-making
• Liver volumes 10% larger than non-drinkers
• Visceral fat levels 15.6% higher than non-drinkers
  

The most surprising part? Changes in organ size were independently linked to brain atrophy, suggesting that alcohol’s effects aren’t siloed; they ripple across systems. This points to a broader, systemic toll that moderate drinking may take on long-term brain health. Learn more: link to full study.

Research participants:

1. Vigilance Health Imaging Network, Vancouver, Canada
2. Prenuvo Inc, Vancouver, Canada
3. Pacific Brain Health Center, Pacific Neuroscience Institute and Foundation, Santa Monica, CA, USA
4. Saint John’s Cancer Institute at Providence Saint John’s Health Center, Santa Monica, CA, USA
5. Washington University School of Medicine in St Louis, Mallinckrodt Institute of Radiology and Department of Neurology, St. Louis, MO, USA

2. Depression reduces brain volume, but exercise may help reverse it

Exercise is widely recommended to improve physical and mental health, but what’s actually happening in the brain when we move our bodies? A large-scale AI-assisted MRI study of 6,458 individuals (1,579 with depression) showed that individuals with depression had significantly smaller brain volumes than those without. However, among those who did exercise, some of that volume was preserved or even increased.

In depressed individuals, exercise was most strongly linked to brain growth in:

• Medial orbitofrontal cortex: Involved in reward, emotion, and decision-making; more volume here may help regulate mood and motivation.
• Lingual cortex: Associated with visual memory and emotional processing.
• Rostral middle frontal cortex and middle temporal cortex: Critical for attention, social reasoning, and interpreting emotional cues.

In non-depressed individuals, exercise showed the greatest impact on:

• Thalamus: The brain’s “relay center” that helps route information between regions.
• Fusiform cortex: Important for facial recognition and visual memory.
• Cerebellum: Known for motor control, but also increasingly recognized for its role in mood and cognition.

This suggests that not only can exercise mitigate the structural brain impacts of depression, but the brain responds differently depending on mental health history. It's a powerful clue in understanding how, and for whom, lifestyle interventions might have the greatest neuroprotective impact. Learn more: link to full study.

Research participants:

1. Vigilance Health Imaging Network, Vancouver, Canada
2. Pacific Brain Health Center, Pacific Neuroscience Institute and Foundation, Santa Monica, CA, USA
3. Saint John’s Cancer Institute at Providence Saint John’s Health Center, Santa Monica, CA, USA
4. Prenuvo Inc, Vancouver, Canada
5. Washington University School of Medicine in St Louis, Mallinckrodt Institute of Radiology, St. Louis, MO, USA
6. Department of Neurology, Washington University in St. Louis, MO, USA
7. Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA

What's next?

Our imaging data is fueling a new wave of AI-powered research across brain health, cancer, internal medicine, and more.

So far, our work has led to 30+ presentations and papers at major conferences like RSNA and AACR. One of our studies on brain volume loss was even named the most-read article of 2023 in the Journal of Aging and Disease.

We’re continuing to partner with leading academic institutions to explore big questions in human health, and we’re doing it with the kind of data that’s never been available at this scale before.